New Orleans City Business: Ochsner Invests In New Orleans-Based Obatala Sciences

New Orleans-based biotechnology firm Obatala Sciences has received a major financial investment from a venture fund led by Ochsner Lafayette General.

The investment from the Healthcare Innovation Fund II will help Obatala continue its manufacturing of stem cell and hydrogel products for next-generation research.

View full article in New Orleans City Business.

Interested in Becoming a Community Partner?

The Fourth Industrial Revolution may be one of the most important conversations of our time.

Help bring next-generation technologies to the US by becoming a New Orleans Community partner.